Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 149

1.
2.

Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review.

Vaswani M, Linda FK, Ramesh S.

Prog Neuropsychopharmacol Biol Psychiatry. 2003 Feb;27(1):85-102. Review.

PMID:
12551730
[PubMed - indexed for MEDLINE]
3.

[Selective serotonin reuptake inhibitor(SSRI)].

Motohashi N.

Nihon Rinsho. 2001 Aug;59(8):1519-22. Review. Japanese.

PMID:
11519151
[PubMed - indexed for MEDLINE]
4.

Pharmacology of rapid-onset antidepressant treatment strategies.

Blier P.

J Clin Psychiatry. 2001;62 Suppl 15:12-7. Review.

PMID:
11444761
[PubMed - indexed for MEDLINE]
5.

SSRIs and SNRIs: broad spectrum of efficacy beyond major depression.

Gorman JM, Kent JM.

J Clin Psychiatry. 1999;60 Suppl 4:33-8; discussion 39. Review.

PMID:
10086481
[PubMed - indexed for MEDLINE]
6.

Predicting response: serotonin reuptake inhibition.

Mendlewicz J.

Int Clin Psychopharmacol. 1999 May;14 Suppl 1:S17-20. Review.

PMID:
10468324
[PubMed - indexed for MEDLINE]
7.

The comparative pharmacology of new antidepressants.

Leonard BE.

J Clin Psychiatry. 1993 Aug;54 Suppl:3-15; discussion 16-7. Review. Erratum in: J Clin Psychiatry 1993 Dec;54(12):491.

PMID:
8253704
[PubMed - indexed for MEDLINE]
8.

Serotonergic systems.

Graeff FG.

Psychiatr Clin North Am. 1997 Dec;20(4):723-39. Review.

PMID:
9443347
[PubMed - indexed for MEDLINE]
9.

[Fluoxetine: an update of its use in major depressive disorder in adults].

Gourion D, Perrin E, Quintin P.

Encephale. 2004 Jul-Aug;30(4):392-9. Review. French.

PMID:
15597466
[PubMed - indexed for MEDLINE]
10.

Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders.

Blier P, de Montigny C.

Neuropsychopharmacology. 1999 Aug;21(2 Suppl):91S-98S. Review.

PMID:
10432494
[PubMed - indexed for MEDLINE]
Free Article
11.

Venlafaxine: a novel antidepressant that has a dual mechanism of action.

Andrews JM, Ninan PT, Nemeroff CB.

Depression. 1996;4(2):48-56. Review.

PMID:
9160640
[PubMed - indexed for MEDLINE]
12.

OCD: where the serotonin selectivity story begins.

Pigott TA.

J Clin Psychiatry. 1996;57 Suppl 6:11-20. Review.

PMID:
8647793
[PubMed - indexed for MEDLINE]
14.

Serotonin selective reuptake inhibitors in child and adolescent psychopharmacology: a review of published experience.

DeVane CL, Sallee FR.

J Clin Psychiatry. 1996 Feb;57(2):55-66. Review.

PMID:
8591970
[PubMed - indexed for MEDLINE]
15.

Therapeutic potential of serotonin antagonists in depressive disorders.

Wood MD, Thomas DR, Watson JM.

Expert Opin Investig Drugs. 2002 Apr;11(4):457-67. Review.

PMID:
11922855
[PubMed - indexed for MEDLINE]
16.

Selective serotonin-reuptake inhibitors: an update.

Masand PS, Gupta S.

Harv Rev Psychiatry. 1999 Jul-Aug;7(2):69-84. Review.

PMID:
10471245
[PubMed - indexed for MEDLINE]
17.

Clinical implications of the pharmacology of serotonin reuptake inhibitors.

Warrington SJ.

Int Clin Psychopharmacol. 1992 Oct;7 Suppl 2:13-9. Review.

PMID:
1484174
[PubMed - indexed for MEDLINE]
18.

Beyond the serotonin reuptake inhibitors: rationales for the development of new serotonergic agents.

Dubovsky SL.

J Clin Psychiatry. 1994 Feb;55 Suppl:34-44. Review.

PMID:
8077173
[PubMed - indexed for MEDLINE]
19.

Possible serotonergic mechanisms underlying the antidepressant and anti-obsessive-compulsive disorder responses.

Blier P, de Montigny C.

Biol Psychiatry. 1998 Sep 1;44(5):313-23. Review.

PMID:
9755353
[PubMed - indexed for MEDLINE]
20.

Antidepressants in panic disorder: clinical and preclinical mechanisms.

Nutt DJ.

J Clin Psychiatry. 1998;59 Suppl 8:24-8; discussion 29. Review.

PMID:
9707159
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk